Actively Recruiting
Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking
Led by Medical University of South Carolina · Updated on 2025-07-14
96
Participants Needed
2
Research Sites
252 weeks
Total Duration
On this page
Sponsors
M
Medical University of South Carolina
Lead Sponsor
N
National Institutes of Health (NIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Investigators primary aim is to carry out a two-site, randomized, double-blind, sham-controlled, phase II trial to systematically examine the potential for aerobic exercise (AEx) to enhance the anti-depressant benefits of rTMS in individuals with post-stroke depression (PSD). Investigators propose to determine the efficacy of combining two known anti-depressant treatments shown to be effective in non-stroke depression, aerobic exercise (AEx) and repetitive transcranial magnetic stimulation (rTMS), on post-stroke depressive symptoms. This project is based on the idea that depression negatively affects the potential for the brain to adapt in response to treatment such that rehabilitation may not produce the same changes that it does in non-depressed individuals. Investigators believe that effective treatment for PSD will result in a virtuous cycle whereby reducing depression enhances response to rehabilitation, thereby facilitating functional gains. That is, effectively treating depression will enable individuals to better recover from stroke.
CONDITIONS
Official Title
Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 21 to 70 years
- Stroke occurred within the past 12 to 60 months
- Positive screen for probable major depressive disorder (PHQ-9 > 10) and HAM-D17 score ≥ 14
- Residual weakness in lower leg with Fugl-Meyer LE motor score < 34
- Able to walk without assistance and no ankle-foot orthosis (AFO) at speeds from 0.2 to 1.0 m/s
- Not currently on antidepressants or stable dosage for at least 4 weeks
- HAM-D17 question #9 (suicide risk) score less than 2
- Able and willing to provide informed consent
You will not qualify if you...
- Unable to walk at least 150 feet before stroke or have intermittent claudication while walking
- History of congestive heart failure, unstable heart rhythms, hypertrophic cardiomyopathy, severe aortic stenosis, angina, or shortness of breath at rest or during daily activities
- History of chronic obstructive pulmonary disease (COPD) or need for oxygen therapy
- History of traumatic brain injury
- Blindness or severe vision impairment
- History of psychosis or other primary Axis I psychiatric disorders
- Life expectancy less than 1 year
- Severe arthritis or other problems limiting testing or training participation
- History of deep vein thrombosis (DVT) or pulmonary embolism within 6 months
- Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions
- Severe high blood pressure with resting systolic > 200 mmHg or diastolic > 110 mmHg
- Suicide attempt within last 2 years or assessed suicidal risk
- History of seizures or currently taking anti-seizure medications
- Currently enrolled in another motor recovery trial
- Currently in behavioral treatment for depression
- Exercising 2 or more times per week for at least 20 minutes
- Contraindications to transcranial magnetic stimulation (TMS)
- Pregnancy or contraindications to MRI
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Duke University School of Medicine
Durham, North Carolina, United States, 27710
Active, Not Recruiting
2
Medical University of South Carolina
Charleston, South Carolina, United States, 29425
Actively Recruiting
Research Team
C
Chris Gregory, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here